What Medications Treat Hidradenitis Suppurativa?
Written by: Ina Fried and Heather Morse | Last reviewed: December 2020
- Seyed Jafari SM, Hunger RE, Schlapbach C. Hidradenitis suppurativa: current understanding of pathogenic mechanisms and suggestion for treatment algorithm. Front Med (Lausanne). 2020 Mar 4;7:68. doi:10.3389/fmed.2020.00068.
- Vinkel C, Thomsen SF. Hidradenitis suppurativa: causes, features, and current treatments. J Clin Aesthet Dermatol. 2018 Oct;11(10):17-23. Available at http://www.ncbi.nim.nih.gov/pmc/articles/PMC6239161/. Accessed 7/26/2020.
- Jemec GBE. Clinical practice: Hidradenitis suppurativa. N Engl J Med. 2012 Jan 12;366(2):158e64. doi:10.1056/NEJMcp1014163.
- Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management. J Am Acad Dermatol. 2019;81(1):91‐101.
- Margesson LJ, Danby FW. Hidradenitis suppurativa. Best Pract Res Clin Obstet Gynaecol. 2014 Oct;28:1013–1027. doi:10.1016/j.bpobgyn.2014.07.012.
- Chen J, Hartmann EM, Kline J, et al. Assessment of human exposure to triclocarban, triclosan and five parabens in U.S. indoor dust using dispersive solid phase extraction followed by liquid chromatography tandem mass spectrometry. Journal of Hazardous Materials. 2018 Oct 15;360:623-630. doi:10.1016/j.jhazmat.2018.08.014.
- Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol. 2019;81(1):76‐90.
- Cyclosporine. MedlinePlus. U.S. National Library of Medicine. Available at https://medlineplus.gov/druginfo/meds/a601207.html. Accessed 8/7/2020.
- Steroids. MedlinePlus U.S. National Library of Medicine. Available at https://medlineplus.gov/steroids.html. Accessed 8/7/2020.
- Napolitano M, Megna M, Timoshchuk EA, et al. Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment. Clin Cosmet Investig Dermatol. 2017;10:105‐115. doi:10.2147/CCID.S111019.eCollection 2017.
- Ngan V. Biological agents for psoriasis: what are biological agents? Topics A-Z. DermNet NZ. Available at https://www.dermnetnz.org/topics/biological-agents-for-psoriasis/. Accessed 8/4/2020
- Constantinou CA, Fragoulis GE, Nikiphorou E. Hidradenitis suppurativa: infection, autoimmunity, or both? Ther Adv Musculoskel Dis. 2019 Dec 30;11:1-14. doi:10.1177/1759720X19895488.
- Kimball AB, Okun MM, Williams DA, et al. Two phase 3 trials of adalimumab for hidradenitis suppurativa, N Engl J Med. 2016 Aug 4;375(5):422-434. doi:10.1056/NEJMoa1504370.
- Mac Mahon J, Kirthi S, Byrne N, et al. An update on health-related quality of life and patient-reported outcomes in hidradenitis suppurativa. Patient Relat Outcome Meas. 2020;11:21-26. doi:10.2147/PROM.S174299.
- Hidradenitis suppurativa (HS): retinoids. National Health System. Available at https://www.nhs.uk/conditions/hidradenitis-suppurativa/. Accessed 7/29/2020.
- Metformin. MedlinePlus U.S. National Library of Medicine. Available at https://medlineplus.gov/druginfo/meds/a696005.html. Accessed 8/7/2020.
- Finasteride. MedlinePlus U.S. National Library of Medicine. Available at https://medlineplus.gov/druginfo/meds/a698016.html. Accessed 8/7/2020.
- Zouboulis CC, Desai N, Emtestam L, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015 Jan;29(4):619-644. doi:10.1111/jdv.12966.